Anti-Mouse RANKL (CD254) - Purified in vivo PLATINUM™ Functional Grade
| Code | Size | Price |
|---|
| LEI-R1368-1.0mg | 1.0 mg | £283.00 |
Quantity:
| LEI-R1368-5.0mg | 5.0 mg | £456.00 |
Quantity:
| LEI-R1368-25mg | 25 mg | £1,335.00 |
Quantity:
| LEI-R1368-50mg | 50 mg | £1,938.00 |
Quantity:
| LEI-R1368-100mg | 100 mg | £2,741.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rat
Antibody Isotype: IgG2a κ
Antibody Clonality: Monoclonal
Antibody Clone: IK22/5
Regulatory Status: RUO
Target Species: Mouse
Applications:
- Blocking
- Flow Cytometry
- Immunoprecipitation (IP)
- In Vivo Assay
- Western Blot (WB)
Shipping:
2-8°C
Storage:
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Further Information
Antigen Distribution:
RANKL is expressed on activated T cells and osteoclasts.
Concentration:
? 5.0 mg/ml
Conjugate/Tag/Label:
Purified in vivo Functional Grade, in vivo PLATINUM™
Format:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Formulation:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Immunogen:
Purified Recombinant Mouse RANKL (NSO-derived)
Long Description:
RANKL antibody, clone IK22/5, recognizes receptor activator of NF-κB ligand (RANKL), also known as CD254, TNF-related activation-induced cytokine (TRANCE), tumor necrosis factor ligand superfamily member 11 (TNFSF11), osteoprotegerin ligand (OPGL), and osteoclast differentiation factor (ODF). RANKL is a type II transmembrane protein belonging to the TNF cytokine superfamily and binds to the signaling receptor, RANK, or decoy receptor, osteoprotegerin (OPG). RANKL is expressed on osteoclasts and is essential for osteoclast differentiation, activation, and survival1. RANKL is also expressed on activated T cells and regulates T cell-dendritic cell (DC) interactions, enhancing DC activation and survival2-3. In addition, RANKL is crucial for lymph node, bone marrow, and thymus development4. Treatment with denosumab, an antibody directed against RANKL, is approved for the treatment of patients at high risk for bone fractures, including osteoporosis, and has shown anti-tumor effects5.
NCBI Gene:
21943
Purity:
?98% monomer by analytical SEC, >95% by SDS Page
Target:
RANKL
References
1. Park JH, et al. (2017) Mol Cells. 40(10):706-713
2. Wong BR, et al. (1997) J Biol Chem. 272(40):25190-4
3. Anderson, D. M., et al. (1997) Nature 390:175.
4. Ono T, et al. (2020) Inflamm Regen. 2020;40:2.
5. de Groot AF, at al. (2018) Cancer Treat Rev. 62:18-28
Related Products
| Product Name | Product Code | Supplier |
|---|